2014 Volume 57 Issue 8 Pages 562-572
For the sake of providing evidences that contribute to policy making or strategy planning in AMED (a Japanese version of the NIH) and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the knowledge flows of the pharmaceutical innovation system, focusing on the patents related with pipelines and drugs, the patents and NPLs cited on the patents by patent examiners and applicants, and the technical fields of cited patents.